查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
血浆衍生物市场:各类型，各用途，各地区- 规模，占有率，展望，机会分析，2023年～2030年
市场调查报告书
商品编码
1330121

血浆衍生物市场:各类型，各用途，各地区- 规模，占有率，展望，机会分析，2023年～2030年

Blood Plasma Derivatives Market, By Type and By Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand' disease, and Other Application) By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3个工作天内

价格
简介目录

血浆是血液的液体部分。血液中大约55%是血浆，其余45%是漂浮在血浆中的红血球、白血球和血小板。使用血浆分馏技术由人类血浆製成的产品称为血浆衍生物。这些用于治疗多种危及生命的疾病。

市场动态：

遗传疾病负担的增加、老年人口的增加、对血浆衍生物的高需求、免疫球蛋白在各个治疗领域的使用增加、血浆采集中心数量的增加预计将在预测期内推动血浆衍生物的全球市场。预计推动经济成长的主要因素

例如，2022 年3 月，赛诺菲SA 和IGM Biosciences, Inc. 同意针对三个肿瘤学和免疫学/发炎靶点创建、开发、製造和商业化免疫球蛋白(IgM) 抗体激动剂。传统的 IgG 抗体具有两个标靶结合位点，而 IgM 抗体具有多达 10 个结合位点并且是多价的，这使得它们有望成为新的治疗剂。

本调查的主要特征

  • 本报告提供以2022年为基准年的预测期间（2023-2030 年）之全球血浆衍生物市场的市场规模和復合年增长率（CAGR %）相关的详区隔析。
  • 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
  • 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
  • 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球血浆衍生物市场的主要参与者之企业简介。
  • 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 全球血浆衍生物市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以透过全球血浆衍生物市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

  • 调查目的
  • 前提条件
  • 简称

第2章 市场概况

  • 报告概要
    • 市场定义和范围
  • 摘要整理
  • Coherent Opportunity Map(COM)

第3章 市场动态，法规，趋势分析

  • 市场动态
    • 遗传性疾病/稀少病患的负担在全世界增加
    • 高额的治疗费与副作用
    • 血浆采取中心的增加
  • 影响分析
  • 主要的焦点
  • 法规情势
  • 产品销售/核准
  • PEST分析
  • 波特分析
  • 合併·收购情势

第4章 血浆衍生物的全球市场-冠状病毒(COVID-19)流行的影响

  • COVID-19流行病学
  • 供给面和需求面的分析
  • 经济影响

第5章 血浆衍生物的全球市场，各类型，2023-2030年

  • 白蛋白
  • 第八凝血因子
  • 第九凝血因子
  • 免疫球蛋白
  • 高免疫球蛋白
  • 其他

第6章 血浆衍生物的全球市场，各用途，2023-2030年

  • 血友病
  • 低伽马球蛋白血症
  • 免疫力缺乏症
  • 冯维勒布兰德氏病(VWD)
  • 其他的应用

第7章 血浆衍生物的全球市场，各地区，2023-2030年

  • 北美
  • 南美
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第8章 竞争情形

  • Shire Plc.
  • CSL Limited
  • Octapharma AG
  • LFB S.A.
  • Biotest AG
  • Grifols, S.A.
  • SK Plasma Co., Ltd.
  • Baxter International Inc.
  • Green Cross Corporation
  • Fusion Health Care Pvt. Ltd.

第9章 章节

  • 调查手法
  • 关于出版社
简介目录
Product Code: CMI5932

Plasma is a liquid portion of blood. About 55% of the blood is plasma, and remaining 45% are red blood cells, white blood cells, and platelets that are suspended in the plasma. Products made from human plasma using plasma fractionation techniques are known as plasma derivatives. These are used in the treatment of various life threatening diseases.

Market Dynamics:

Rise in burden of genetic diseases, increasing geriatric population, high demand for blood plasma derivatives, growing use of immunoglobulins in various therapeutic areas, and increasing number of plasma collection centres are major factors expected to augment the growth of the global blood plasma derivatives market during the forecast period.

For instance, in March 2022, Sanofi SA and IGM Biosciences, Inc. collaborated to create, develop, manufacture, and commercialize immunoglobulin (IgM) antibody agonists against three oncology and immunology/inflammation targets. Engineered antibodies represent a new class of potential therapeutics that combine the multi-valency of antibodies possessing 10 binding sites compared to conventional IgG antibodies having only 2 target binding sites.

Key features of the study:

  • This report provides in-depth analysis of the global blood plasma derivatives market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global blood plasma derivatives market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Shire Plc., CSL Limited, Octapharma AG, LFB S.A., Biotest AG, Grifols, S.A., SK Plasma Co., Ltd., Baxter International Inc., Green Cross Corporation, and Fusion Health Care Pvt. Ltd., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global blood plasma derivatives market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood plasma derivatives market.

Detailed Segmentation:

  • Global Blood Plasma Derivatives Market, By Type:
    • Albumin
    • Factor VIII
    • Factor IX
    • Immunoglobulin
    • Hyperimmune Globulin
    • Other
  • Global Blood Plasma Derivatives Market, By Application:
    • Hemophilia
    • Hypogammaglobulinemia
    • Immunodeficiency Diseases
    • Von Willebrand' disease (VWD)
    • Other Application
  • Global Blood Plasma Derivatives Market, By Geography:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles:
    • Shire Plc.
    • CSL Limited
    • Octapharma AG
    • LFB S.A.
    • Biotest AG
    • Grifols, S.A.
    • SK Plasma Co., Ltd.
    • Baxter International Inc.,
    • Green Cross Corporation
    • Fusion Health Care Pvt. Ltd.

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rise in burden of genetic/rare diseases worldwide
    • High cost of treatment/therapy and side effects
    • Increasing number of plasma collection centres
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Blood Plasma Derivatives Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Blood Plasma Derivatives Market, By Type, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Albumin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Factor VIII
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Factor IX
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Immunoglobulin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Hyperimmune Globulin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Global Blood Plasma Derivatives Market, By Application, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Hemophilia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Hypogammaglobulinemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Immunodeficiency Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Von Willebrand Disease (VWD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Other Application
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

7. Global Blood Plasma Derivatives Market, By Region, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)

8. Competitive Landscape

  • Shire Plc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CSL Limited
  • Octapharma AG
  • LFB S.A.
  • Biotest AG
  • Grifols, S.A.
  • SK Plasma Co., Ltd.
  • Baxter International Inc.
  • Green Cross Corporation
  • Fusion Health Care Pvt. Ltd.
  • Analyst Views

9. Section

  • Research Methodology
  • About us